The American Journal of Medicine
Volume 105, Issue 3, Supplement 1 , Pages 66S-73S, 28 September 1998

Parallels between post-polio fatigue and chronic fatigue syndrome: a common pathophysiology?

  • Richard L Bruno, PhD

      Affiliations

    • Kids’ Fatigue Management Program, Englewood Hospital and Medical Center, Englewood, New Jersey USA
    • The Post-Polio Institute, Englewood Hospital and Medical Center, Englewood, New Jersey, USA
    • Harvest Center, Hackensack, New Jersey, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Richard L. Bruno, PhD, The Post-Polio Institute, Englewood Hospital and Medical Center, 350 Engle Street, Englewood, NJ 07631
  • ,
  • Susan J Creange, PhD

      Affiliations

    • Kids’ Fatigue Management Program, Englewood Hospital and Medical Center, Englewood, New Jersey USA
  • ,
  • Nancy M Frick (LhD)

      Affiliations

    • Harvest Center, Hackensack, New Jersey, USA

published online 16 August 2004.

Abstract 

Fatigue is the most commonly reported and most debilitating of post-polio sequelae affecting the >1.8 million North American polio survivors. Post-polio fatigue is characterized by subjective reports of difficulty with attention, cognition, and maintaining wakefulness. These symptoms resemble those reported in nearly 2 dozen outbreaks of post-viral fatigue syndromes (PVFS) that have recurred during this century and that are related clinically, historically, anatomically, or physiologically to poliovirus infections. This article reviews recent studies that relate the symptoms of post-polio fatigue and chronic fatigue syndrome (CFS) to clinically significant deficits on neuropsychologic tests of attention, histopathologic and neuroradiologic evidence of brain lesions, impaired activation of the hypothalamic–pituitary–adrenal axis, increased prolactin secretion, and electroencephalogram (EEG) slow-wave activity. A possible common pathophysiology for post-polio fatigue and CFS, based on the Brain Fatigue Generator Model of PVFS, and a possibile pharmacotherapy for PVFS based on replacement of depleted brain dopamine, will be described.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This research was supported by grants from the George A. Ohl, Jr., Infantile Paralysis Foundation

PII: S0002-9343(98)00161-2

The American Journal of Medicine
Volume 105, Issue 3, Supplement 1 , Pages 66S-73S, 28 September 1998